Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | INPP5A | Q14642 | 3/20 | 0.52 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.37 |
| ▸ | ITPR3 | Q14573 | 7/20 | 0.36 |
| ▸ | ITPR2 | Q14571 | 3/20 | 0.36 |
| ▸ | ITPR1 | Q14643 | 3/20 | 0.36 |
| ▸ | INPPL1 | O15357 | 1/20 | 0.34 |
| ▸ | AKT1 | P31749 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2238965 | 0.87 | — | — | |
| SCHEMBL9484912 | 0.86 | INPP5A (0.38) | INPP5AACHECYP19A1 | |
| SCHEMBL9629720 | 0.80 | ACHE (0.35) | INPP5AACHECYP19A1 | |
| SCHEMBL2238021 | 0.77 | — | — | |
| SCHEMBL2149479 | 0.77 | INPP5A (0.52) | INPP5ASMPD1ITPR3ITPR2ITPR1 | |
| Methyl Alcohol SCHEMBL28863308 | 0.76 | INPP5A (0.47) | INPP5ASMPD1ITPR3ITPR2ITPR1 | |
| SCHEMBL25657149 | 0.76 | INPP5A (0.47) | INPP5ASMPD1ITPR3ITPR2ITPR1 | |
| SCHEMBL18231183 | 0.76 | INPP5A (0.32) | INPP5AACHE | |
| SCHEMBL19808281 | 0.76 | INPP5A (0.43) | INPP5ASMPD1 | |
| SCHEMBL14412710 | 0.75 | INPP5A (0.50) | INPP5ASMPD1ITPR3ITPR2ITPR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4134098-A1 | METHOD OF CANCER THERAPY | ONO Pharmaceutical Co., Ltd. (JP) | 2023-02-15 | — | — | EP | disclosed |
| EP-4134134-A1 | STING AGONISTIC COMPOUND | ONO Pharmaceutical Co., Ltd. (JP) | 2023-02-15 | — | — | EP | disclosed |